Menu

Events

2025 Taiwan-Japan Investment and Industry Networking Event (April 23)

Due to full enrollment, we will close the application today. Thank you very much for your application. (4/17)

This event serves as a platform to connect Taiwan companies with Japanese investors and enterprises, fostering diverse opportunities for resource integration, strategic alliances, and business collaborations. 
By strengthening bilateral collaboration in the biotechnology and pharmaceutical sectors, the event aims to further expand partnerships in industrial development, technological innovation, and international market expansion.
 

Date: Wednesday, April 23, 13:20 – 17:00

Venue:
Application

(Opens an external site)

Registration due date

Thursday, April 17 

Program

TimeAgenda
13:00-13:20Registration
13:20-13:22Welcome Address

Biotechnology Pharmaceutical Industries Promotion Office (BPIPO) 
Dr.Michael Huang/Director
 
13:22-13:35Opening Remarks  
Development Center for Biotechnology (DCB)
Dr.Shiing-jer Twu/Chairman 

Life Sceience Innovation Network Japan(LINK-J)
Mr.Akihiko Soyama/Chief Executive Officer 

Forum for Innovative Regenetive Medicine(FIRM)
Dr.Masayuki Nomura/Chair of IAC
Mr.Kunihiko Suzuki/Chair of SPCC
13:35-13:45Group Photo Session
13:45-13:55Strategic Partnership Agreement Signing Ceremony
DuoGenic StemCells corporation x A&I Corporation
Taiwan-Japan Investment and Industry Networking Moderator: Mr.KuniChou
13:55-14:03Ministry of Economy Trade and Industry(METI)
Mr. Keita  Komatsu
Deputy Deirector of the Bio-Industry Division
14:03-14:11DCI Partners Co., Ltd.
Mr. Shuntaro Kodama 
Senior Managing Director
14:11-14:19DuoGenic StemCells corporation
Dr. Hong-Lin Su 
Chairman
14:19-14:27Human Life CORD Japan inc.
Dr. Akihito Nakata 
Executive Officer
14:27-14:35AngenMed Therapeutics, Inc.
Dr. Shuen-iu Hung 
CEO
14:35-14:43Teijin Limited
Dr. Takashi Yamamoto 
General Manager
14:43-14:51GoldNanoTech. Inc
Mr. Tang Shan Wen 
Chairman
14:51-14:59Mochida Pharmaceutical Co., Ltd.
Dr. Konghua Lin 
General Manager
14:59-15:07LumiSTAR Biotechnology, Inc.
Dr. Chih-Chuan Su  
Senior Business Development Manager
15:07-15:20Break Time
15:20-15:28CSL Behring
Mr. Yasufumi Wada 
R&D Innovation Japa
15:28-15:36BIONET Therapeutics Corp.
Ms. Fiona Tsai 
Special Assistant to General Manager
15:36-15:44PeptiGrowth Inc.
Mr. Kazuki Shigematsu 
Technical support specialist for marketing
15:44-15:52HeXun Biosciences Co., Ltd.
Dr. Sung Yuan Chen 
Vice General Manage
15:52-16:00iHeart Japan Corporation
Mr. Zxian Jiang
Proffesional
16:00-16:08Ascension Medical Biotechnology CO., LTD.
Dr. Richard Shieh 
Chairman
16:08-17:00Networking

The organizer reserves the right to adjust the agenda.

Speakers

1.Japan: FIRM、DCI、investors and companies 
2.Taiwan: 10~15 Companies (with a focus on regenerative medicine and new drug development)

Participation Fee

Participation Free

Capacity

70persons

Organizer

Organized by Biotechnology and Pharmaceutical Industries Promotion Office, MOEA (BPIPO)
Co-organized by Life Science Innovation Network Japan (Link-J) & Development Center for Biotechnology (DCB)
 

Contact

If you have any questions about this form, please contact to BPIPO:
Cindy:slc@biopharm.org.tw
Lynn:lynn@biopharm.org.tw
 

Date: Wednesday, April 23, 13:20 – 17:00

Venue:
Application

(Opens an external site)

Registration due date

Thursday, April 17 

pagetop